tocoretinate has been researched along with Vitiligo in 1 studies
*Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, S; Kikuchi, K; Komine, M; Ohmatsu, H; Ohtsuki, M; Tada, Y; Tamaki, K; Wu, CS; Yu, HS | 1 |
1 other study(ies) available for tocoretinate and Vitiligo
| Article | Year |
|---|---|
Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo.
Topics: Administration, Topical; Animals; Cell Proliferation; Drug Combinations; Guinea Pigs; Humans; Indicators and Reagents; Keratinocytes; Male; Skin Pigmentation; Tretinoin; Vitamin E; Vitiligo | 2013 |